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EDITORIAL
EGF receptor activation by G-protein coupled receptors
One of the central tenets of cell activation by growth receptor activation of non-receptor-mediated tyrosine
factors and hormones has been that a ligand binds spe- kinases of the Janus kinase (Jak) family that then phos-
cifically to its cognate receptor, and activates receptor- phorylate substrate proteins called STATs (signal trans-
dependent binding and specific cellular responses. How- ducers and activators of transcription). The phosphory-
ever, recent studies have determined that this paradigm lated STAT proteins move to the nucleus, bind specific
does not adequately explain the intracellular signaling DNA elements, and direct transcription [1].
pathways activated by the binding of an individual ligand More recently, ligand binding to a number of GPCRs
to its receptor. Increasing evidence has suggested that has also been shown to result in tyrosine kinase cascades.
activation of one class of receptors can lead to transacti- GPCRs represent the largest group of cell-surface recep-
vation of a different class of receptors that eventuates tors and consist of seven transmembrane domains with
in signal transduction pathways. Specifically, ligand bind- an extracellular amino terminus and an intracellular car-
ing to a number of G-protein coupled receptors (GPCRs) boxy terminus. Ligand binding results in binding, activa-
can induce transactivation of the epidermal growth factor tion and dissociation of heterotrimeric G proteins, with
(EGF) receptor, which mediates tyrosine kinase cas- initiation of intracellular signaling response by Ga and
cades of intracellular signaling. Gbg subunits. The nature of the signaling responses is
The EGF receptor is a classic example of the receptor largely dependent upon the identity of the a subunit of
tyrosine kinase (RTK) class, which mediates a broad the heterotrimeric G proteins and includes modulation
range of growth factor-dependent physiologic cellular of adenylate cyclases, PLCb and kinases. The determina-
responses, including proliferation, differentiation, sur- tion that GPCR-mediated activation of ERK/MAP ki-
vival and motility. A family of structurally related pro- nases was dependent upon tyrosine phosphorylation of
teins, including EGF, transforming growth factor-a SHC and formation of a SHC/Grb2 complex suggested
(TGF-a), amphiregulin, heparin-binding EGF (HB- that GPCR also activated tyrosine kinases. Subsequently,
EGF), betacellulin and epiregulin, serve as agonists for a number of GPCRs, including endothelin, adrenergic,
the EGF receptor. Activation of the intrinsic tyrosine angiotensin II, purogenic, muscarinic, LPA, thrombin
kinase of the EGF receptor in response to ligand binding and bombesin receptors, have been shown to induce tyro-
results in phosphorylation of a subset of the receptor’s sine phosphorylation and association of signaling mole-
tyrosine residues that create binding sites for Src homol- cules to the EGF receptor. Either pharmacologic inhibi-
ogy 2 (SH2) and phosphotyrosine binding (PTB) do- tion of tyrosine kinase activity or expression of dominant
main-containing proteins. The molecules that are re- negative EGF receptors prevents the mitogenic responses
cruited to these sites represent either enzymes that are elicited by GPCRs [2].
activated as a result of tyrosine phosphorylation, such There is evidence that this GPCR-regulated transacti-
as Src, phospholipase Cg (PLCg) and phosphatidyl-ino- vation of the EGF receptor may be mediated by activa-
sitol-3 kinase (PI3 kinase) or adaptor molecules (SHC) tion of the non-receptor tyrosine kinase c-Src, or src-
that activate downstream signaling pathways, such as like tyrosine kinases [3]. Src is known to phosphorylate
MAP kinase pathways, as a result of formation and re- and associate with the EGF receptor, and pharmacologic
ceptor association of a Shc-Grb2-SOS complex and in- inhibitors of Src, dominant negative Src constructs or
duction of Raf function. overexpression of Csk, a tyrosine kinase that negatively
Tyrosine kinase-mediated signaling pathways have regulates Src function, all inhibit GPCR transactivation
long been recognized to mediate the cellular responses of the EGF receptor. In this issue of Kidney Interna-
resulting from ligand binding to RTKs such as the EGF tional, Bokemeyer, Schmitz and Kramer demonstrate
receptor. Subsequently, it was discovered that receptor that in vascular smooth muscle, angiotensin II activates
activation of receptors without intrinsic tyrosine kinase
the EGF receptor through a c-Src dependent pathway,
activity could also induce tyrosine kinase cascades. An
which results in activation of both Erks and PI-3 kinase.example of such a signaling pathway is interferon alpha
Angiotensin II-induced mitogenesis in these cells was
inhibited by either EGF receptor-specific inhibitors or
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nase cascades by GPCRs is an area of active investiga- docking protein, Gab1 [11]. Therefore, an alternative or
additional means for EGF receptor transactivation maytion. There is indication that Gi and Gbg subunits activate
be through secondary autocrine activation, in whichSrc family kinases, which then mediate EGF receptor
GPCR activation induces metalloproteinase-dependentphosphorylation without activation of the intrinsic recep-
cleavage of EGF receptor ligands, which then activatetor tyrosine kinase. In contrast, for Gq coupled receptors,
the EGF receptor and initiate EGF receptor-dependentEGF receptor tyrosine kinase inhibitors and receptor
signaling pathways.mutants prevent signal transduction, suggesting that re-
In summary, these exciting discoveries concerningceptor activation is necessary for signal transduction
GPCR-dependent EGF receptor transactivation have[3, 5]. Such a mechanism of action is consistent with
taught us that the perceived dichotomy between GPCR-the studies of Bokemeyer et al, since AT1 receptors in
mediated- and RTK-mediated-signaling pathways mayvascular smooth muscle cells are coupled predominantly
be false and that cell activation by different classes ofto Gq-mediated signaling pathways [6].
agonists initiates crosstalk that results in utilization ofThe activation of Src by certain GPCRs has been
common signaling pathways.reported to be mediated through the activation of the
cytoplasmic tyrosine kinase PYK2, which is activated by
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